Patent application number | Description | Published |
20090076005 | Kinase inhibitor compounds - The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes. | 03-19-2009 |
20100261665 | Kinase inhibitor compounds - The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes. | 10-14-2010 |
20100294348 | Thin film solar module - This invention discloses a thin film solar module of see-through structure comprising a solar cell segment and a light-transmitting region, wherein the solar cell segment comprises an insulating transparent substrate, a first electrode layer, a semiconductor layer and a second electrode layer that are sequentially deposited on the insulating transparent substrate, namely, the solar cell segment comprises a plurality of photo-electric conversion units connected in serial; and wherein the light-transmitting region comprises a plurality of light-transmitting square holes that are formed by partly removing the second electrode layer and the semiconductor layer in the solar cell segment. The see-through thin film solar module of this invention, besides ensuring the light-transmitting required for curtain walls of architectures, can improve the uneven distribution of energy when circular light-transmitting holes are formed using laser and solve the problem that a short circuit can easily occur in a see-through thin film solar module, thereby enhancing its power generation performance. | 11-25-2010 |
20110130395 | P13K ISOFORM SELECTIVE INHIBITORS - 2-Morpholin-4-yl-9H-purine and 5-Morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine derivatives, especially those substituted by 6-heteroaryl, are unexpected PI3 kinase isoform selective inhibitors with good drug properties and are useful in treating disorders related to abnormal PI3K activities such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine disorders and neurological disorders. | 06-02-2011 |
20110160209 | SUBSTITUTED PYRIDAZINE CARBOXAMIDE COMPOUNDS AS KINASE INHIBITOR COMPOUNDS - Pyridazine derivatives have unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as cancer. | 06-30-2011 |
20110224212 | KINASE INHIBITOR COMPOUNDS - The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes. | 09-15-2011 |
20110281857 | PI3K/MTOR KINASE INHIBITORS - 6-morpholin-4-yl-pyrazolo[3,4-d]pyrimidine and 2-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine derivatives have unexpected drug properties as inhibitors of PI3 and/or mTOR kinases and are useful in treating disorders related to abnormal PI3K/mTOR activities such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine disorders and neurological disorders. | 11-17-2011 |
20120115866 | KINASE INHIBITOR COMPOUNDS - The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes. | 05-10-2012 |
20120220629 | ASYMMETRIC UREAS AND MEDICAL USES THEREOF - Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I): | 08-30-2012 |
20140121210 | ASYMMETRIC UREAS AND MEDICAL USES THEREOF - Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I): | 05-01-2014 |
20140221376 | SUBSTITUTED PYRIDAZINE CARBOXAMIDE COMPOUNDS AS KINASE INHIBITOR COMPOUNDS - Pyridazine derivatives have unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as cancer. | 08-07-2014 |